AI assistant
Riber — Earnings Release 2011
Jul 19, 2011
1629_iss_2011-07-19_747915e9-e802-49ba-ac94-3fea56d58a23.pdf
Earnings Release
Open in viewerOpens in your device viewer
Tripling of half-year revenues to €13 million
Bezons, July 19th, 2011 – 5:45 pm – RIBER, the global leader for molecular beam epitaxy (MBE), recorded €13.0 million in revenues for the first half of 2011, up 198% in relation to the first half of 2010. Revenues for the second quarter of 2011 came to €7.2 million, compared with €1.5 million for the second quarter of 2010.
With an order book representing €18.0 million at June 30th, 2011, RIBER is forecasting €27 to 29 million in full-year revenues.
| €'000,000 | H1 2011 | H1 2010 | Change |
|---|---|---|---|
| Systems | 3.4 | 1.1 | +198% |
| Services and accessories | 2.6 | 2.7 | - 4% |
| Cells and sources | 7.0 | 0.5 | x13 |
| Total reported revenues | 13.0 | 4.4 | +198% |
| Systems order book | 15.1 | 13.4 | +12.4% |
| Services and accessories order book | 1.7 | 2.3 | -26.8% |
| Cells and sources order book | 1.2 | 1.2 | +2.8% |
| Total order book | 18.0 | 16.9 | +6.4% |
During the first half of the year, three research systems with high unit values were delivered, compared with two for the first half of 2010.
Sales of services and accessories are stable in relation to 2010.
Business over the half-year period was marked by the increase in sales of evaporation sources and cells. They came in 13 times higher than the first half of 2010 thanks to the delivery of the first significant orders on the strongly-growing OLED (Organic LED) and thin-film solar panels (CIGS technology) markets.
Outlook: business to grow by over 30% in 2011
The order book at June 30th, 2011 represented €18.0 million, an increase of 6.4% in relation to June 30th, 2010. It consists of six research systems and four production systems, with three machines to be delivered after 2011. In addition to this amount, a major order was sealed at the beginning of July 2011 for OLED production equipment (cells). The services and accessories order book is down temporarily in relation to 2010, although this does not call into question the business outlook for the year.
These results are in line with RIBER's strategic model, which is based on profitable growth drivers:
- Continuing to further strengthen RIBER's leadership on the market for molecular beam epitaxy machines;
- Continuing to capitalize on the installed base and growing sales of epitaxy equipment, spare parts and accessories, as well as the corresponding services;
- Rolling out a diversification policy, releasing a range of high value-added equipment (cells and sources) on the market for strong-growth application fields (thin-layer solar cells, OLED lighting and screens, etc.).
For 2011, RIBER is targeting revenue growth of between €27 and 29 million, an increase of around 35% in relation to 2010, paving the way for strong growth in operating income.
Next date: 2011 first-half earnings - Tuesday September 13th, 2011
About RIBER:
tel: +33 1 39 96 65 00 [email protected]
| Riber designs and produces molecular beam epitaxy (MBE) systems as well as evaporation sources and cells for the semiconductor | ||||
|---|---|---|---|---|
| industry. This high-technology equipment is essential for the manufacturing of compound semiconductor materials and new materials that | ||||
| are used in numerous consumer applications, such as new information technologies, OLED flat screens and new generation solar cells. | ||||
| Riber is listed on Euronext Paris Compartment "C" and is part of the CAC Small, CAC Mid & Small and CAC IT indexes. | ||||
| ISIN: FR0000075954 Reuters code: RIBE.PA Bloomberg code: RIB: FP | ||||
| Riber has been innovation certified by OSEO, the dedicated French innovation agency, enabling it to qualify for French innovation mutual | ||||
| funds (FCPI). | ||||
| RIBER | CALYPTUS | |||
| Olivier Handschumacher | Cyril Combe |
www.riber.com
tel: +33 1 53 65 68 68 [email protected]